The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, C4 Therapeutics Inc (NASDAQ: CCCC) closed at $5.38 up 0.75% from its previous closing price of $5.34. In other words, the price has increased by $0.75 from its previous closing price. On the day, 0.54 million shares were traded. CCCC stock price reached its highest trading level at $5.48 during the session, while it also had its lowest trading level at $5.18.
Ratios:
For a deeper understanding of C4 Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.09. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.
On December 13, 2023, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $2 to $12.
Credit Suisse Upgraded its Underperform to Neutral on February 24, 2023, whereas the target price for the stock was revised from $12 to $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CCCC now has a Market Capitalization of 373037376 and an Enterprise Value of 177356112. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.70 while its Price-to-Book (P/B) ratio in mrq is 1.50. Its current Enterprise Value per Revenue stands at 6.037 whereas that against EBITDA is -1.546.
Stock Price History:
Over the past 52 weeks, CCCC has reached a high of $11.88, while it has fallen to a 52-week low of $1.06. The 50-Day Moving Average of the stock is -12.16%, while the 200-Day Moving Average is calculated to be -16.88%.
Shares Statistics:
For the past three months, CCCC has traded an average of 1.25M shares per day and 773240 over the past ten days. A total of 60.47M shares are outstanding, with a floating share count of 57.36M. Insiders hold about 17.27% of the company’s shares, while institutions hold 82.32% stake in the company. Shares short for CCCC as of 1726185600 were 11923240 with a Short Ratio of 9.50, compared to 1723680000 on 10503384. Therefore, it implies a Short% of Shares Outstanding of 11923240 and a Short% of Float of 20.91.
